IDEAYA Biosciences

IDYANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.832 B

$39.71 +2.19%

Close of 22 Sept 2026

Revenue

$218.7M

#2257 by revenue

Earnings

-$113.7M

Loss-making

Shares outstanding

96,489,484

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#66AbCellera BiologicsABCL$4.10B
#67Telix PharmaceuticalsTLX$4.05B
#68IDEAYA BiosciencesIDYA$3.83B
#69Xenon PharmaceuticalsXENE$3.79B
#70Legend BiotechLEGN$3.63B

What if IDEAYA Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$313,339.53

Per share 7,891× higher

Bitcoin $1.74T

$18,050.21

Per share 455× higher

Nvidia $5.52T

$57,164.44

Per share 1,440× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for IDEAYA Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.